Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hls / Pfizer - Canada
For HLS - a no brainer teaming up with Pfizer/ its existing sales force- job done -great way to selling more in Canada no risk / infrastructure cost or time issue
Interesting to Remember in this equation that Amarin had a fairly long lasting sales arrangement previously with another company which Amarin brought to a close - how did that do ??
But here For Pfizer - anyone seriously think they are interested in the small beer commission they will make on this deal - why divert their sales force to sell another companies product -? they have plenty a product to sell already
This is so not about commission for Pfizer
So what in reality is it about ?
A test to see if we can sell it before we buy Amarin - ?how long a test ? 6 months - a year -If they can’t sell V - well what’s the point buying the company ?
But if it sells well through Pfizer - where do they go from there??
It’s a litmus test
Alm
Marjac
Great news .... great work .... agree your tactic of filing early ...you know your case inside out and your brief will already set out fully what your case is ... it won’t mature with time ... it is complete perfection itself of that I am sure
Keep the time pressure on the opposition and time - given the age of certain of the desired FC panel and hope they might take it -getting it in early assists!!
And it adds additional fuel to the other litigation fire
Forever in your debt
Alm
Prepare-It results -covid- Amarins share price
I bow to others more scientifically minded as to whether there will be a significant benefit from taking Amarin to reduce covid adverse effects - but my reading of those who have expressed views is that there is every reasonable reason to expect a very positive outcome
So we had a great life saving drug before -helps people who might get a heart attack etc —
The difference here is -covid -as to the possible impact on Amarins share price
Covid has the worlds attention and all of humanity desperately want to escape the restrictions that covid has placed upon people their lives and the world of business
The common view -So lots of people die of heart attacks ... they are generally old and infirm .
But the covid view-..hey I can catch covid at 30 and die and if I don’t die suffer from long covid and all the things that entails - I want to feel safe that I can go to clubs bars restaurants the game I want my life back - if I get covid - hey give me Vascepa it will make be better stop me dying and getting long covid - it’s great no side effects
So if some pill that is cheap and has no side effects does a great job at preventing folk from being ill / hospitalised/ dying / getting long covid then Amarin will have the worlds attention
Alm
Tasty
Will you do all the charts from now on ?? ..... yours have real meaning and are so easy to follow - although I found it difficult to know which way the cleavage shape set out in the chart would take us ... are we going up big time or are we going down ??...either way I just suddenly didn’t care !!
Alm
Settlement - we need ask ourselves why would Hikma settle ? What is their risk? Their downside if they settle
- sets a precedent ( not necessarily a legal one ) that all pharma companies would follow against generics to protect their labels from skinny abuse - the life blood of generic business
If they don’t settle - triple damages ?? How much exactly .... they will have to way potential profit from generic sales against the damages they would have to pay .... how much would that be ????
If they think the financial risk is huge and can somehow duck the skinny label issue they may settle
When would they settle ???? Now ???
Not likely ... they know they can settle at the doors of the trial court- so 2023???
And what will they do between now and trial date ?? Assuming they have supply - will they flood the market with gv....or will they reign it in so they are not skinny label infringing as demonstrated by percentage of sales
What we have now is a new game/ phase in litigation that gives Amarin much more muscle - get the awaited gsk ruling on side and we have more muscle
And let’s not forget .... Marjac and team Rule 24/60
That would not be muscle in a battle for market but generic slaughter - a victory for truth and justice righting the appalling Du decision which has been so appallingly ignored by the American justice system
The Rule 24/60 case - needs a Federal Court panel who are judges that are prepared to deliver justice
Marjac may yet deliver the killer blow to the generic rip off merchants that we all so long to see
Alm
Marjac
Your endeavour is incredibly important and your endeavour beyond comparison
I and I am sure all are eternally grateful to you. I look forward to being simply awed in the reading of it
Alm
Marjac
Your endeavour is incredibly important and your endeavour beyond comparison
I and I am sure all are eternally grateful to you. I look forward to being simply awed in the reading of it
Alm
Irish
When we reach 22 we will rejoice together ...
Alm
jas .... sorry original got posted twice !
Buy back is difficult - they have cash but I suspect they will want to keep such to cover extra running costs of Europe set up and cash in reserve is always healthy
Bod buying even small quantities send the same message that they put their money on their own future success - and Karim would be well to lead the way - others have referred to suspension of benefits package - well again Karim - a sales expert - would be as well to create a far more success of company reward based system than the present gifted for free no matter how poor the companies performance - but such changes don’t happen overnight
The company has been quiet awhile - the silence of the old -we hope -to make way for the clamour of the new
The company has to GIA until it’s bought if that is ever to happen - the market hates nothing more than a “ no plans” approach - Amarin needs to communicate effectively - with its customers / Drs and with the market which includes retail investors who make up the vast majority of shareholders
Raf has repeatedly pointed out the frankly backward half hearted approach to communication right across the company
They need slick marketers - from their PR company all the way through the whole company structure
The GIA success of the company depends on sales sales sales and Karim is a sales focused new CEO - he needs to kick the USA sales team up the ass from very top to bottom - sell or your out for the sales reps - they either shift V or they don’t have a job
The market will notice solid sales figures quarter on quarter and the company making regular profits increasing quarter on quarter
Maybe covid treatment or some such will explode sales - Pdude whose work is incredible assesses very positively the likely Argentinian trial outcome
In short better times should lie ahead .... the companies performance as to execution under Theo was very poor and he led the patent disaster because the buck stops with the CEO - he should have fallen on his sword within a few months of that debacle
Alm
Jas
I haven’t posted for a while - the board has taken on a very depressed short term view- ok we all should have sold in the 20’s
I just bought more shares in Amarin
Ok - so the SP under 4 - what does that tell us ??
It tell us nothing about the real value or potential value of this company if you take a long view -
Things have to change in the way the business has been operated-communication communication communication
Things will now change with the new regime - there will be a revitalisation- Karim has to show he is a ballsy dynamic new CEO- and
Let us not forget
The patent litigation war is far from over - I am a lawyer - appalled by the Du case —A travesty of justice but an inept failure by the company to protect its patents - they sat on their laurels and got stuffed by the deviousness of generic litigation - but
The patent loss has so far only hit a tops reduction of less than 15 per cent
The Europe/ China /Row market is one of immense potential
The drug is likely to have huge impact in other areas - covid/alz..et al
The co may yet attract a buyer
Will this share be trading at 4 in five years time ??
I predicted 22 by end of year -around the average view in rafs poll -
Ok - the average and I are going to be wrong - we seemed on our way at 9 after Europe approval
But will we get there in the years ahead - 2 or 3 years maybe 5
I will be happy to get to 22 in 5 years time that will be a 5 fold increase in my assets
I can wait ...
Alm
Jas
I haven’t posted for a while - the board has taken on a very depressed short term view- ok we all should have sold in the 20’s
I just bought more shares in Amarin
Ok - so the SP under 4 - what does that tell us ??
It tell us nothing about the real value or potential value of this company if you take a long view -
Things have to change in the way the business has been operated-communication communication communication
Things will now change with the new regime - there will be a revitalisation- Karim has to show he is a ballsy dynamic new CEO- and
Let us not forget
The patent litigation war is far from over - I am a lawyer - appalled by the Du case —A travesty of justice but an inept failure by the company to protect its patents - they sat on their laurels and got stuffed by the deviousness of generic litigation - but
The patent loss has so far only hit a tops reduction of less than 15 per cent
The Europe/ China /Row market is one of immense potential
The drug is likely to have huge impact in other areas - covid/alz..et al
The co may yet attract a buyer
Will this share be trading at 4 in five years time ??
I predicted 22 by end of year -around the average view in rafs poll -
Ok - the average and I are going to be wrong - we seemed on our way at 9 after Europe approval
But will we get there in the years ahead - 2 or 3 years maybe 5
I will be happy to get to 22 in 5 years time that will be a 5 fold increase in my assets
I can wait ...
Alm
Marjac
I am watching you quietly from afar ... we both know what you can achieve -,your fortitude is a glowing example to us all
Go get them ...
Alm
Marjac
Cool - cooler than absolute zero !!!
This time ..... they will have to address the facts not engage in lawyer character assassination... but I know you have very thick skin and adopt the correct and exemplary approach of riding above it
Alm
Marjac
Great legal work
Great confidence
Great determination
Great lawyer
Grateful thanks from us all -
Reading your Brief in August can’t come soon enough !
Alm
Marjac and 8
Supreme Court was always A very long shot but it’s disappointing when we all feel the wrong of the Du decision should be righted by a sophisticated justice system
But nothing changed today -the patents for one indication had been lost in Nevada they remain intact for cvd
You are right - the fight continues - the infringement case is very difficult for generics and it is clearly holding them back as does supply
And Marjac could yet pull a killer blow to right the wrong of Du
This all has a long way to travel yet
Alm
Marjac
Great news
Alm
Marjac
We are with you all the way... keep moving it on ...great work
Alm
Zip ....
And diversification into other markets - like every country in Europe -they aren’t going to go into gold mining
They need their cash to run the business so most unlikely they would be buying another company
It is all just very vague and nothing to get excited about
Alm
Oneragman
Right in relation to the sale by Hikma as GV -but only for non CV application - the Delaware case is all about H infringement-by selling to CV usage for which patents remain entirely valid - so you have to split your analysis accordingly
Alm
Marjac.... you keep doing what you do .... you never loose faith
We will prevail .... and thanks to you and the team for all you do
Alm
Donations to appeal
I have just donated 500dollars
It needs a lot more of you to do the same
Marjac and the team are busting gut here .... we need to help them on the way
Alm
Lem
Keep the faith
It will work out
Alm
Marjac
Absolutely spot on - the article had no in depth research into either the facts or the case law
It did not amount to an opinion on anything but simply spewed out DU’s decision
The appeal has great merit
I can’t wait to read the brief
Alm
Larry bird legend
I just acquired another 7000 shares because - a -I expect you are right and b- they are giving the shares away at this SP
Better times ahead
Alm
Marjac
Understood - was not sure FC would automatically be seized of the Rule 60 on the appeal of DU’s decision of Rule 24
Seems little point your seeking to have her adjudicate on Rule 60 if appeal successful on Rule 24 - she would find a way to throw Rule 60 out even if forced to rule upon it - however much will rest on the which panel is drawn in FC - Newman and Moore please !!!!
Alm
9 and Marjac - Appeal
Appeal will be on standing Rule 24 -not on the Rule 60
If appeal won on standing FC simply send case back to Du-???” we find they have standing now Judge Du consider the Rule 60 “”
So then Du considers Rule 60 - Du rejects (would we expect anything else?)
So Appeal then on Rule 60 ???
This may take some time .....
Alm
Pharmacydude
Great call
Great read
Justice will be done !!
Alm
Marjac
I agree entirely with you that she has been incorrect to rule that this was not a timely application
The earliest point in time to have made the application must be from the point where the fraud or the mistake was revealed - up to a point of12 months after the judgement - for after that point in time no such application can be made - the civil procedures set this as the cut off point in time
Now if the fraud and mistake were known a month after the judgement - but were not litigated until 364 days later then there could be a basis to find it was not timely (even then it would be the circumstances that dictate )
Timely is dictated with a 12 month cut off point after judgement but does not apply until the obviousness of what is asserted became known where the court has ruled based upon to serious error or fraud
Alm
Louieblouiie/marjac /hindukush/ Jason et al
We all feared Standing was the easy way out And it has been taken.... and the shallowness of the reasoning for denial speaks volumes as to the embarrassment of the Nevada court
-but let us all be clear what this team effort has achieved is immeasurable-
The right has been clearly set out for all to see and
I hope that all of you who were so closely involved will feel rewarded not by the failure of this motion through standing but by virtue of the fact that you have so clearly demonstrated the gross error of the Du courts decision as to obviousness
Success has been achieved by your exposure of where the truth actually lies - and this may well have been the cause of the shake up we are now seeing in Amarin
The legal battle continues - infringement proceedings face no issue of standing for Amarin and the battle there has only just begun
And who knows what influence on the SC the motion may have exerted ...for surely the documentation you created will be considered in the mill
My heartfelt thanks to you all for your sublime endeavours
Alm
L/ marjac / HK / Jason
I hub communications with Amarin
L— suggestion as to the shareholder group
What we lack is a group of committed shareholder communication link to Amarin
Lots of posters have really good observations - for example Ralphy as a dr dealing with Amarin reps and insurance on the ground but also lemmi and others as to Amarin tweets /
You name it there are great points being raised - but no central focus - some posters post to Amarin others just don’t bother
If we could establish a pressure group of shareholders not just for legal action but for direct communication to Amarin that would be a huge step forward
The posters could forward to a centralised communicator with Amarin
Can you and the present team think about this - Marjac / HK / Jason
We loose traction ... we have virtually no traction presently
Alm
Insync
Absolutely spot on logic
The generic V market is dying and will soon be dead ....
Alm
Ralphy please send all of these first hand experiences to Amarin
Vital they see it as it is on the ground
Alm
Jasbg. The change of CEO does not reflect any change in the value of the company - one CEO to another and the shares are suddenly worth a dollar less ??? What’s that all about ??
The shares have been down to 4 previously and up to 9 -(last 12 months) but on what basis ? Nothing much has changed on the sales front in that time
So it’s all about perception presently ...
Simple answer to it all is to grow sales and grow profits - that’s the new CEO job - big job and he had better do it ....
If of course there is a litigation win then perception will change some yet again
Amarin has to get its sales and profits moving
It will take time ... 12 months from now where will sales be ?... two years from now ??
The Sp will be stuck at 4 to 7 or 8 for some time to come now unless a big change blows in
No fun / not a great place to be.. but we will have to stick it out - hopefully in 12 months time we will be posters with some good things to contemplate
Alm
USA market
Crazy to think it is zero
For one thing it will certainly continue for at least the next 12 months at the same level as now in that generics won’t make further inroads until litigation over and it should take at least that long
Even if lost the whole of the USA market would not disappear totally - and still there maybe further new litigation ahead over infringement which would slow erosion
But winning any of the three legal battles would set the USA back up completely
The key is now profitable sales growth over time
That’s the new CEO job
Alm
ralphy
Whist Dr reddy may have intended to enter the market they can see first hand that litigation could await them as to infringement if they did and over and above there are clearly issues facing generics (as per Hikma) as to supply
One suspects that no other generic will wish to enter the market until litigation is over - a years wait for example
-Would probably be enough to allow the litigation to clear -if Amarin fails in litigation on the three fronts they can then come into the market without concern
So I doubt anyone else will join the generic party for a long time -and let us hope never on the basis of success in litigation
Alm
Ralphy/North
I consider north’s suggestion a great idea and it maybe that a letter from a concerned citizen who is also a practising doctor working as it were at the coal face of dealing with client suffering from heart conditions/ diabetes and so forth is very well placed to present such a letter
Might I suggest without wishing to burden you both that Ralphy and North liaise over such to see what can be best presented to the court
Alm
8- firstly I don’t think you or indeed anyone can protect any reader from gaining incorrect impressions - that will happen no matter who tries to police posts on the board - I doubt you have time or inclination to be the policeman
Secondly you are going way over the top on L - what she stated was quite acceptable/ hardly outrageous/ easily clarified
Thirdly as a lawyer who has practised over 40 years I have seen many times over non lawyers reaching quite valid and indeed sometimes highly compelling interpretations of a legal position - I would never shut the door on a layman having his or her view
Whilst we may be lawyers I would hope we would listen and respect a layman’s right to a view on any legal matter - I have seen at certain times in my career lay defendants doing a brilliant job defending the most complex and serious of matters - way beyond their pay grade
Finally we could all benefit from just letting things wash over a while - Amarin has been a long story with many ups and many downs - I know you are a committed supporter of the cause we longs all share - I really hope for you and your family (as well as for me and mine) that things will come good - it won’t be for lack of dedication and commitment
Your input on legal matters has been greatly appreciated by me and I am sure all board members- thank you for all your efforts
Alm
Louieblouie-well said- good for you girl - 8 was being very hard on you - as a lawyer I would hope for a little less heavy handed approach - think most posters can work out where matters stand on the Rule 24 motion - let us all with patience hope for success
My view is that you are doing a simply great job and I hope we all would encourage you to keep on doing what you do - I for one certainly appreciate all you and the team have done -
Alm
Sales reps in USA
Apparently now number 600 not 800- lots of posters overstate the USA sales rep numbers
I am Sure the new CEO will create a new focus on cost effective marketing /focus on PR and cost effective advertising
Sales sales sales —- and profit profit profit are now the key - both in USA and in Europe - along with developing new markets geographically and as to usage for example covid ??
Litigation is ongoing on three fronts - 2 via Amarin -one from shareholders - Rule 60
If any one succeeds USA is back on track - even without litigation success the USA market may remain substantial
Making enough V may yet be a limiting factor ahead
Under Thero the sales / marketing/ PR was beyond stagnant and not cost effective
When Amarin starts making good profits the SP will increase
It’s a how long does it take question...one year? - eighteen months max ??
That’s Probably how long The new CEO will have to turn things around - and he knows it
If it’s not happening by then he will be on his way out ...
Alm
Share price
Does it really matter whether the share moves down or up 50 cents on this news ??
What is really important is
1 what happens in relation to legal proceedings to preserve the USA market
2 how you move this company into increasing sales and grow a profit
will the new CEO generate new focus into making this a growing profitable business ...?? That’s the big test for him
. Thero has been CEO - for past year or so sadly the company has well and truly stagnated (covid played its part) but above all he else steered the ship into the most devastating and totally avoidable patent loss
Time was ripe for change - the new CEO could do worse ??? But unlikely
Dramatic change could occur - Fortune will shine on him and this company if one of 3 sets of proceedings bears fruit -
but big cost effective marketing changes need to be made to get sales up and make profits
The right result in legal proceedings and 12 months of a new sales direction which works will see the SP move up 5 dollars and maybe 10
And who knows what interest BP this may arose ....
Alm